夏威夷髋部骨折住院后骨质疏松治疗率低
该回顾性病历回顾纳入夏威夷一个大型医疗系统内三家社区医院2015年1月1日至2016年5月31日因髋部骨折住院的≥50岁患者428例,评估骨折后1年内骨质疏松药物治疗和DEXA检查情况。仅115例(26.9%)接受骨质疏松药物作为二级预防,137例(32.0%)接受DEXA检查,多数治疗患者使用口服双膦酸盐。治疗机构、女性性别和较高BMI是骨质疏松治疗的预测因素;作者结论认为骨质疏松药物使用率低,需努力提高治疗率,尤其是男性。
要点
- 髋部骨折住院后1年内仅26.9%(115/428)患者接受骨质疏松药物治疗。
- 仅32.0%(137/428)患者接受DEXA检查,多数治疗患者使用口服双膦酸盐。
- 治疗机构、女性性别和较高BMI是骨质疏松治疗的预测因素。
核心结论
- 夏威夷髋部骨折住院后骨质疏松药物用于二级预防的使用率低,需努力提高治疗率,尤其是男性。
研究设计与样本
- 回顾性病历回顾,纳入2015年1月1日至2016年5月31日在夏威夷太平洋健康(Hawaii Pacific Health)三家主要医院因髋部骨折住院的≥50岁患者428例。
主要发现
- 髋部骨折住院后1年内,仅115例(26.9%)患者被处方骨质疏松药物作为二级预防。
- 137例(32.0%)患者进行了DEXA扫描。
- 大多数接受治疗的患者被处方口服双膦酸盐。
- 治疗机构、女性性别和较高BMI被发现是骨质疏松治疗的预测因素。
关键数值与推荐
- 骨质疏松药物治疗率26.9%(115/428),DEXA检查率32.0%(137/428)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We evaluated osteoporosis treatment and DEXA utilization rates of patients who were admitted for hip fracture in a single healthcare system in Hawaii from 2015 to 2016. We found that osteoporosis treatment and DEXA utilization rates were low, highlighting a critical gap in osteoporosis care after admission for hip fracture. INTRODUCTION: The objective of this study was to evaluate osteoporosis care after an admission for hip fracture at three community hospitals within a single healthcare system in Hawaii. METHODS: A retrospective chart review was conducted (n = 428) of patients ≥ 50 years and hospitalized for hip fractures between January 1, 2015, and May 31, 2016, at three major hospitals within Hawaii Pacific Health, a large healthcare system in Hawaii. Basic demographics were collected, and medications prescribed were quantified and described within 1 year of hip fracture. Logistic regression was used to evaluate the association between collected variables and the odds of osteoporosis treatment. RESULTS: Only 115 (26.9%) patients were prescribed a medication for osteoporosis as a secondary prevention within a year of hospitalization for hip fracture. DEXA scans were performed in 137 (32.0%) patients. Most of the treated patients were prescribed oral bisphosphonates. Treatment facility, female gender, and higher BMI were found to be predictive factors for osteoporosis treatment. CONCLUSION: The use of osteoporosis medication for secondary prevention after admission for hip fracture in Hawaii is low. Efforts need to be made to improve treatment rates, especially among males.
引用
- Nguyen ET, Posas-Mendoza T, Siu AM, et al. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Osteoporos Int. 2018. PMID: 29744567. doi:10.1007/s00198-018-4553-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。